. ASP-azo-ASA is a colon-specific prodrug activated to form ASP and 5-ASA. ASP-azo-ASA (1.0 mM) was incubated in cecal contents suspended in pH 6.8 isotonic phosphate buffer (10%). At appropriate time intervals, the levels of ASP in the samples were determined by high-performance liquid chromatography. Data represent the percentage of ASP released from ASPazo-ASA and are represented as the mean ± standard deviation (n = 5). Figure S2 . Representative images of the distal colons of rats following oral gavage of drugs.
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Three-days after the induction of colitis by DNBS, ASP-azo-ASA (39 mg/kg) or SSZ (30 mg/kg) suspended in PBS (1.0 mL) was administered to rats by oral gavage once per day and the rats were sacrificed after 7 days of treatment. The serosal and luminal sides of isolated distal colons were photographed. Figure S3 . ASP-azo-ASA is more effective than SSZ in decreasing the levels of inflammatory cytokines in the inflamed distal colon of rats. To measure levels of interleukin-6 (A, IL-6), tumor necrosis factorα (B, TNF-α), and IL-1β (C) in the inflamed tissues, the inflamed distal colon was homogenized in appropriate buffers for immunoassay of each cytokine and centrifuged at 10,000 ×g at 4 °C for 10 min. An appropriate volume of the supernatant was used to determine cytokines' levels using ELISA kits. The data represent the mean ± standard deviation (n = 5). * P < 0.05 vs control, # P < 0.05. Figure S4 . Anti-colitic effects of ASP-azo-ASA are associated with colonic delivery of ASP and 5-ASA. Three-days after the induction of colitis by DNBS, ASP-azo-ASA (39 mg/kg) or a mixture of 5-ASA (12 mg/kg) and ASP (28 mg/kg) suspended in PBS (1.0 mL) was administered to rats by oral gavage once per day and the rats were sacrificed after 7 days of treatment. (A) Representative images of the serosal and luminal sides of isolated distal colons (B). The CDS was determined. *: α < 0.05 vs. the DNBS control (C). MPO activity was measured using inflamed distal colons (4 cm). The levels of inflammatory mediators, iNOS, COX-2 (D), and CINC-3 (E), were assessed in the inflamed colon. * P < 0.05 vs control. The data in B, C, and E represent the mean ± standard deviation (n = 5). * P < 0.05 vs control, # P < 0.05. Three-days after the induction of colitis by DNBS, 5-ASA (30 mM) and/or ASP (30 mM) suspended in PBS (0.5 mL) at pH 7.4 were/was administered rectally to rats once per day and the rats were sacrificed after 7 days of treatment. The serosal and luminal sides of isolated distal colons were photographed
